| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.17 | 9e-07 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-06 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.15 | 2e-05 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | 0.15 | 6e-05 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.15 | 9e-05 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.21 | 0.0001 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |